Cargando…

Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio)

AIM: We studied the diagnostic potential of serum lactate dehydrogenase (LDH) in malignant pleural effusion. METHODS: Retrospective analysis of patients hospitalized with exudative pleural effusion in 2013. RESULTS: Serum LDH and serum LDH: pleural fluid ADA ratio was significantly higher in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verma, Akash, Abisheganaden, John, Light, R. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740559/ https://www.ncbi.nlm.nih.gov/pubmed/26678281 http://dx.doi.org/10.1007/s00408-015-9831-6

Ejemplares similares

Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)
por: Verma, Akash, et al.
Publicado: (2016)

Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion
por: Verma, Akash, et al.
Publicado: (2016)

Age : pleural fluid ADA ratio and other indicators for differentiating between tubercular and malignant pleural effusions
por: Zhou, Jiupeng, et al.
Publicado: (2022)

Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion
por: Hackner, Klaus, et al.
Publicado: (2019)

Pleural Fluid Serum Bilirubin Ratio for Differentiating Exudative and Transudative Effusions
por: Agrawal, Pawan, et al.
Publicado: (2018)

Adenosine Deaminase (ADA) Level in Tubercular Pleural Effusion
por: Verma, S.K., et al.
Publicado: (2008)

Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion
por: Rabbi, Mohammad Fazle, et al.
Publicado: (2023)

Diagnostic accuracy of pleural fluid to serum carcinoembryonic antigen ratio and delta value for malignant pleural effusion: findings from two cohorts
por: Jiang, Meng-Ping, et al.
Publicado: (2023)

A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion
por: Lin, Liyan, et al.
Publicado: (2021)

Correction to: Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion
por: Rabbi, Mohammad Fazle, et al.
Publicado: (2023)

Is albumin gradient or fluid to serum albumin ratio better than the pleural fluid lactate dehydroginase in the diagnostic of separation of pleural effusion?
por: Joseph, Jose, et al.
Publicado: (2002)

Total Protein–Chloride Ratio in Pleural Fluid Independently Predicts Overall Survival in Malignant Pleural Effusion at the First Diagnosis
por: Qiao, Xin, et al.
Publicado: (2022)

The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion
por: Düzköprü, Yakup, et al.
Publicado: (2017)

The diagnostic value of pleural fluid homocysteine in malignant pleural effusion
por: Santotoribio, Jose D., et al.
Publicado: (2019)

Clinical Value of Pleural Effusion and Serum MMP-3 and CYFRA21-1 Combined with ADA in Differential Diagnosis of Pleural Exudative Effusion
por: Xu, Zhiyang, et al.
Publicado: (2022)

The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions
por: Wang, Jinlin, et al.
Publicado: (2017)

Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions
por: Korczynski, P, et al.
Publicado: (2009)

Age affects the diagnostic accuracy of the cancer ratio for malignant pleural effusion
por: Huang, Jin-Hong, et al.
Publicado: (2023)

Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions
por: Sorolla, Maria Alba, et al.
Publicado: (2021)

Pleural Fluid-to-Blood BNP Ratio May Contribute to Prognosis in Malignant Pleural Mesothelioma
por: Tsolaki, Vasiliki, et al.
Publicado: (2023)

Diagnosis of parapneumonic pleural effusion with serum and pleural fluid Activin A
por: Zhou, Guanghui, et al.
Publicado: (2022)

Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion
por: Gayaf, Mine, et al.
Publicado: (2021)

Pleural Fluid Resolution Is Associated with Improved Survival in Patients with Malignant Pleural Effusion
por: MacRosty, Christina R., et al.
Publicado: (2023)

Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers, Using Mathematical Methods
por: Darooei, Reza, et al.
Publicado: (2017)

Diagnostic accuracy of pleural fluid lactate dehydrogenase to adenosine deaminase ratio for tuberculous pleural effusion: an analysis of two cohorts
por: Yan, Zhi, et al.
Publicado: (2022)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance
por: Popowicz, Natalia, et al.
Publicado: (2021)

Diagnosis of Parapneumonia Pleural Effusion with Serum and Pleural Fluid Cell-Free DNA
por: Su, Chih-Min, et al.
Publicado: (2019)

Differentiating between tuberculous and non-tuberculous pleural effusions using the pleural fluid ratio of 10× adenosine deaminase/lactate dehydrogenase
por: Li, Yan, et al.
Publicado: (2023)

Combining ADA, Protein and IFN- γ Best Allows Discrimination Between Tuberculous and Malignant Pleural Effusion
por: Kim, Young-Chul, et al.
Publicado: (1997)

Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion
por: Ren, Zenghua, et al.
Publicado: (2021)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
por: Sriram, Krishna B, et al.
Publicado: (2012)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

Pleural Fluid Cholesterol in Differentiating Exudative and Transudative Pleural Effusion
por: Hamal, A. B., et al.
Publicado: (2013)

Pleural Fluid Pentraxin-3 for the Differential Diagnosis of Pleural Effusions
por: Yeo, Chang Dong, et al.
Publicado: (2013)

Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions
por: JI, QIAOYING, et al.
Publicado: (2014)

The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study
por: Wu, Huimin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lklm519bgsmuf49s4tnjpga4du